<DOC>
	<DOCNO>NCT00004041</DOCNO>
	<brief_summary>RATIONALE : Inserting gene adenovirus p53 person 's tumor may improve body 's ability fight cancer . PURPOSE : Phase I trial study effectiveness gene therapy treat patient recurrent malignant glioma .</brief_summary>
	<brief_title>Gene Therapy Treating Patients With Recurrent Malignant Gliomas</brief_title>
	<detailed_description>OBJECTIVES : I . Determine biological effect molecular level intratumoral administration adenovirus p53 gene ( Ad-p53 ) patient malignant primary glioma . II . Determine maximum tolerate dose intratumoral Ad-p53 patient . III . Evaluate qualitative quantitative toxicity intratumoral Ad-p53 patient population . OUTLINE : This dose-escalation , multicenter study . Patients receive initial intratumoral stereotactic injection adenovirus p53 ( Ad-p53 ) 10 minute day 1 . In absence unacceptable toxicity result initial injection , patient undergo tumor resection receive series 1-minute injection Ad-p53 resect tumor cavity wall day 4 . Cohorts 3-6 patient receive escalate dos Ad-p53 . If 2 3 3 6 patient experience dose limit toxicity ( DLT ) particular dose level , escalation cease maximum tolerate dose define previous dose level . Patients follow closely 12 week , every 2 week 8 week , every 4 week 8 week , every 8 week death . PROJECTED ACCRUAL : A maximum 30 patient accrue study .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically prove malignant primary glioma Glioblastoma multiforme Anaplastic oligodendroglioma Gliosarcoma Mixed malignant glioma Anaplastic astrocytoma Clear evidence tumor recurrence progression CT MRI within 2 week prior study fail prior best surgical resection radiation Surgically accessible tumor resection indicate Tumors great 2.0 cm diameter Tumor extend ventricular system PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 70100 % Life expectancy : Not specify Hematopoietic : Absolute granulocyte count least 1,500/mm3 Platelet count least 100,000/mm3 No evidence bleed diatheses Hepatic : SGPT great 2 time upper limit normal ( ULN ) Alkaline phosphatase great 2 time ULN Bilirubin le 1.5 mg/dL Renal : BUN le 1.5 time ULN OR Creatinine le 1.5 time ULN Cardiovascular : Not specify Pulmonary : Not specify Other : No active uncontrolled infection Must afebrile ( le 38.0 degree Celsius ) No unstable serious medical condition HIV negative Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Prior chemotherapy allow ( least 2 week since prior vincristine , 3 week since prior procarbazine , 6 week since prior nitrosoureas ) recover Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics At least 4 week since prior radiotherapy Surgery : See Disease Characteristics Other : No prior concurrent anticoagulant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2002</verification_date>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult mixed glioma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>